Enhancement of endocannabinoid signaling and the pharmacotherapy of depression.
about
Is lipid signaling through cannabinoid 2 receptors part of a protective system?GPR55, a G-protein coupled receptor for lysophosphatidylinositol, plays a role in motor coordination.Developmental regulation of fear learning and anxiety behavior by endocannabinoids.Long-term consequences of perinatal fatty acid amino hydrolase inhibition.Altering endocannabinoid neurotransmission at critical developmental ages: impact on rodent emotionality and cognitive performance.Cannabinoid CB1 receptor immunoreactivity in the prefrontal cortex: Comparison of schizophrenia and major depressive disorder.Deficiency in endocannabinoid signaling in the nucleus accumbens induced by chronic unpredictable stress.Substrate-selective COX-2 inhibition decreases anxiety via endocannabinoid activationMonoacylglycerol lipase inhibition blocks chronic stress-induced depressive-like behaviors via activation of mTOR signaling.Brain CB₂ Receptors: Implications for Neuropsychiatric Disorders.In vivo pharmacology of endocannabinoids and their metabolic inhibitors: therapeutic implications in Parkinson's disease and abuse liabilitySelective alterations of the CB1 receptors and the fatty acid amide hydrolase in the ventral striatum of alcoholics and suicidesDysfunction in fatty acid amide hydrolase is associated with depressive-like behavior in Wistar Kyoto rats.Differential effects of the antidepressants tranylcypromine and fluoxetine on limbic cannabinoid receptor binding and endocannabinoid contents.Regional alterations in the endocannabinoid system in an animal model of depression: effects of concurrent antidepressant treatment.Cannabinoids and Dementia: A Review of Clinical and Preclinical Data.Selective inhibition of alpha/beta-hydrolase domain 6 attenuates neurodegeneration, alleviates blood brain barrier breakdown, and improves functional recovery in a mouse model of traumatic brain injuryMetabolic disturbances connecting obesity and depression.The endocannabinoid system in the regulation of emotions throughout lifespan: a discussion on therapeutic perspectives.Metabolomics of postprandial plasma alterations: a comprehensive Japanese study.The cannabinergic system is implicated in the upregulation of central NGF protein by psychotropic drugs.Subjective effects of cannabis before the first psychotic episode.
P2860
Q24633122-C885A0DB-B6D6-42A4-97EE-F85E01D4CDC7Q28508581-62F6243E-7449-4B1E-8E6B-037AF3DC6D73Q30366747-02C6D30B-9C87-4F0D-AF7E-C23F51371511Q30417555-2156412F-E0A1-46A2-9EB5-AA89B9E851F6Q30471167-A7FA6184-6D1F-414D-B18D-62815E530FF2Q30497212-16EDAD3A-CA7C-4A45-A901-1F994DBFE60FQ30498533-F2BBA004-5191-4134-871B-22E8F11392DEQ30547823-23618B2C-E3CE-4797-BB0E-F81CBD116490Q33620621-C172040B-5150-40D3-B772-013A60E0AFB4Q33664105-EF581BED-4105-40E4-8E63-05C7CD16ACF2Q33751118-0EC33FC0-433C-40B3-874A-9C1B9BDD9E88Q33886361-56C17E3A-BE9A-47B6-B7A7-8B07CBF8B496Q34273681-52507F4E-C596-4D2A-907A-7399D21C988EQ34356390-6265978A-A549-4149-9B29-43DD1289D68FQ34798544-402EE9E4-504D-4EA2-AF1E-2CDD60706B8CQ36155898-8564CF54-6260-40E7-B58E-6A8064603EC5Q36795890-74E252B9-0154-4B7B-8814-1D4D0BF55B30Q37217434-5CFC831D-04EC-4BE7-AE4B-BB80430C30F2Q37892742-C1F2E47D-2646-4EAA-A5BA-B3ADF30B95C2Q47776433-88D6BC23-3485-4D9F-AA80-761391F1302DQ48944762-1226CCAD-C52E-437B-AE21-0EE9A4B47B7BQ50716534-DD82C615-5629-4E6D-A6F3-A115F2F4E544
P2860
Enhancement of endocannabinoid signaling and the pharmacotherapy of depression.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Enhancement of endocannabinoid signaling and the pharmacotherapy of depression.
@ast
Enhancement of endocannabinoid signaling and the pharmacotherapy of depression.
@en
type
label
Enhancement of endocannabinoid signaling and the pharmacotherapy of depression.
@ast
Enhancement of endocannabinoid signaling and the pharmacotherapy of depression.
@en
prefLabel
Enhancement of endocannabinoid signaling and the pharmacotherapy of depression.
@ast
Enhancement of endocannabinoid signaling and the pharmacotherapy of depression.
@en
P2860
P1476
Enhancement of endocannabinoid signaling and the pharmacotherapy of depression
@en
P2093
Daniele Piomelli
P2860
P304
P356
10.1016/J.PHRS.2007.09.003
P577
2007-09-11T00:00:00Z